作者
Dilip Mathai, M Todd Lewis, Kari C Kugler, Michael A Pfaller, Ronald N Jones, C Staley, Summa Health System, Good Samaritan Regional Medical Center, Denver General Hospital, Albuquerque Hospital, PC Schreckenberger, Froedtert Memorial Lutheran Hospital-East, VAMC Boston, MA Boston, Columbia Presbyterian Medical Center, NY New York, Long Island Jewish Medical Center, Strong Memorial Hospital, Kaiser Regional Laboratory, Sacred Heart Medical Center, WA Spokane, Medical Center, St Louis Barnes-Jewish Hospital, Parkland Health, Dallas Hospital System, Galveston University of Texas Medical Branch at Galveston, Louisville Hospital, MS Jackson, Charlotte Carolinas Medical Center, Medical Center, CAN Alberta, II Queen Elizabeth, Ottawa General Hospital, SENTRY Participants Group
发表日期
2001/2/1
期刊
Diagnostic microbiology and infectious disease
卷号
39
期号
2
页码范围
105-116
出版商
Elsevier
简介
Pneumonia is the second most frequent cause of nosocomial infection, and hospitalization frequently is needed for community-acquired pneumonia. Knowledge of causative pathogens through periodic surveillance, and their prevailing antimicrobial susceptibility patterns becomes paramount in choosing appropriate empiric therapy. The SENTRY Antimicrobial Surveillance Program, tracks pathogen distribution worldwide since 1997 and documents emerging resistance to a wide range of antimicrobial agents. During the respiratory disease season in 1998, each of 30 medical centers (25 in the United States [US], and five in Canada [CAN]) contributed 100 consecutive isolates obtained from hospitalized patients with suspected pneumonia. The 2773 organisms, processed by the monitor consisted of a total of 35 species, with Staphylococcus aureus comprising 25.6% of all isolates and five other species …
引用总数
200120022003200420052006200720082009201020112012201320142015201620172018201920202021491579955322551524211